Advanced Breast Cancer Patients, Focusing On Patient’s Reported Outcomes In Reducing The Burden Of Financial Toxicity
Researched by Belong.Life, Published by the The Breast. 2019 A targeted survey of Belong.life Advanced Breast Cancer (ABC) patients (pts), focusing on patient’s reported outcomes (PROs), real world evidence (RWE) and insights in reducing the burden of financial toxicity (FT) Background: 151 ABC pts, active Belong.life users, the world largest, anonymous and free social media […]
Implementation of a Person Centered e-Health Platform in Gynecological Cancer Care In JGH
Researched By Belong.Life with JGH and Presented by McGill University, 2019 This study was conducted by McGill University and the Jewish General Hospital in Toronto, Canada, using the Belong.life platform. Authors: Saima Ahmed, Walter H. Gotlieb, Guy Erez , Carmen G. Loiselle Introduction: Enhanced population health is increasingly supported by e-health – defined as technological […]
Financial Toxicity In Cancer Patients Receiving Immunotherapy Drugs
Researched by Belong.Life and published by ESMO, 2020 Authors: D Vorobiof, L Hasid, A Litvin, I Deutsch, E Malki. FT has been described as the harmful personal financial burden faced by all patients receiving cancer treatments. Physicians should not be waiting for behavioural changes such as poor compliance, or low or nonadherence, caused by financial […]
Financial Toxicity in American Patients Receiving Cancer Immunotherapy Drugs
Researched by Belong.Life and published by ASCO, 2020Authors: Daniel A. Vorobiof, Lior Hasid, Alon Litvin, Irad Deutsch, Eliran Malki Background: Real-word data obtained through cutting edge technology paired with consumer mobile devices on 310 worldwide pts, members of Belong.life, an international mobile application, who received immunotherapy for diverse solid tumors, was obtained following a short, […]
Physician’s Advice On BRCA Genetic Testing For Ovary And Breast Cancer Patients
Researched by Belong.Life and published by ASCO 2020 Author: Daniel A. Vorobiof Background:The 2019 US Preventive Services Task Force (USPSTF) recommends that women with a personal and familiar history of BC and OC undergo a BRCA genetic testing so that risk assessment, prevention options and treatment changes are considered. Methods:BC and OC members of Belong.life […]
Real-world evidence data (RWED) of Financial Toxicity in Patients Receiving Cancer Immunotherapy Treatments
Researched by Belong.Life and published by ASCO 2020 Authors: D A Vorobiof, L Hasid, I Deutsch, A Litvin, E Malki Abstract: RWED of financial toxicity was reported by the majority of cancer pts receiving Immunotherapy drugs for treatment of their solid tumors. 48% of the pts were aware of possible FTs as a result of […]
Using a digital patient powered research network to identify outcomes of importance to patients with multiple myeloma
Authors: Katharine S. Gries & John Fastenau Background: Social media platforms give patients a voice by allowing them to discuss their health and connect with others. These unfiltered and genuine reports offer direct access to what matters most to patients. Exploring the patient-reported outcomes discussed in these platforms reveal clinical insights and behavioral patterns of […]
Covid 19 vaccines in cancer patients (pts), real-world data (RWD) from 1069 Belong.life users
Authors: Eli Sapir, Noy Moisa, Alon Litvin, Eliran Malki, Daniel Vorobiof, Assuta Ashdod Hospital Background: The COVID-19 pandemic continues to have a serious impact on cancer pts management. At the end of December 2020, the US CDC and oncology groups (ASCO, ESMO, ACS) made general vaccine recommendations for cancer pts. Methods: HODS 1069 patients, users […]
Evaluating the dyadic management of sexuality-related parameters in women with early breast cancer (EBC): The emergence of “partner reported outcome measurements” (pROMs).
Researched by Belong.Life and published by ASCO Authors: Eli Sapir, Benjamin W. Corn, Lior Hasid, Irad Deutsch, Daniel A. Vorobiof Background:Patient-centered healthcare has focused on incorporating the values of patients (Pts) during clinical decision-making. Accordingly, assessments are often executed with patient reported outcome measurements (PROMs). In the context of tumors located in a sexual organ, […]
Clinical trials participation is directly influenced by the information received by cancer patients (pts) and caregivers: Real-world evidence with the use of a specialized digital health platform.
Researched by Belong.Life and published by ASCO Authors: Keren Greenfeld-Barsky, Lior Hasid, Daniel A. Vorobiof, Eliran Malki Background: Clinical trials (CT) participation is both crucial for medical advancement and an important treatment option, at times the only one, for oncological pts. However, only an estimate of ~3% of cancer pts worldwide enrolls into such trials. […]
